Voyager Therapeutics Stock Price

0.20 (4.47%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Voyager Therapeutics Inc VYGR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.20 4.47% 4.67 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.47 4.43 4.68 4.67 4.47
Bid Price Ask Price Spread News
4.17 4.73 0.56 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,016 305,723 $ 4.54 $ 1,387,110 471,859 4.35 - 14.62
Last Trade Time Type Quantity Stock Price Currency
18:39:16 4 $ 4.56 USD

Voyager Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 174.97M 37.47M 25.88M $ 104.39M $ 33.41M -1.27 8.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Voyager Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VYGR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.674.874.354.60378,8960.000.0%
1 Month5.595.714.354.77418,873-0.92-16.46%
3 Months8.778.954.356.05517,329-4.10-46.75%
6 Months11.5412.004.357.17446,632-6.87-59.53%
1 Year10.0014.624.359.04357,049-5.33-53.3%
3 Years17.9028.794.3514.40388,803-13.23-73.91%
5 Years12.4531.914.3515.01319,690-7.78-62.49%

Voyager Therapeutics Description

Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's and Alzheimer's disease. The company has developed products such as VY-AADC01 for Advanced Parkinson's Disease, VY-HTT01 for Huntington's Disease. Voyager's sole source of revenue is generated through its collaboration with a company called Genzyme. Genzyme funds the collaboration for the multiple gene therapy programs, including programs for Parkinson's disease, Friedreich's ataxia, and Huntington's disease, as well as other CNS disorders.

Your Recent History
Voyager Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.